NIH-funded research R21 grant

Non-Invasive AI-Enhanced Neonatal Blood Pressure Monitoring in NICUs

Official title: BPAlert: A Non-Invasive, AI-Enhanced, Continuous Blood Pressure Monitoring System for Neonates in NICU

Funded at Rutgers, the State Univ of N.j. · NIH-11442500 · Data updated 2026-11-12

A new AI-powered system uses the baby’s existing sensors to continuously track blood pressure in the NICU without invasive procedures, helping clinicians spot problems early.

More Blood Pressure research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRutgers, the State Univ of N.j.
NIH-funded
Lab location1 site (Piscataway, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2029
Funding year2026
Award (this year)$235,500
NIH project number1R21EB040115-01
Project IDNIH-11442500 on NIH RePORTER

Who could benefit from this research

Could help

Newborns in NICUs who require BP monitoring and can be safely observed with non-invasive sensors.

Less likely to help

Newborns for whom non-invasive monitoring is not feasible or in whom PPG-based signals cannot be obtained.

What this research studies

This project aims to provide continuous, non-invasive blood pressure monitoring for newborns in the NICU by combining AI-driven estimations of BP changes with periodic cuff measurements. The system relies on photoplethysmography, a light-based signal already used for oxygen monitoring, and a self-explaining AI design to show clinicians why a prediction is made. By focusing on BP changes over short intervals rather than absolute values, it seeks to improve accuracy and generalizability across patients while maintaining transparency. An integrated alarm component will alert care teams when BP changes signal potential sepsis or organ issues, supporting timely clinical decisions.

Why it matters

Potential benefit: If successful, this system could enable continuous BP monitoring with fewer invasive procedures, potentially improving early detection of critical conditions in newborns.

How similar studies have gone: Prior AI-based BP-estimation efforts exist, but this approach emphasizes ∆BP estimation and self-explaining AI to improve reliability and clinician trust.

Where this research is happening

  • Rutgers, the State Univ of N.j.
    Piscataway, United States
    Active

Researchers

  • Principal investigator: Najafizadeh, Laleh — Rutgers, the State Univ of N.j.
  • Study coordinator: Najafizadeh, Laleh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.